C
Kiniksa Pharmaceuticals International, plc KNSA
$31.98 $1.725.68% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 529.33M 481.17M 423.24M 384.10M 338.93M
Total Other Revenue -- -- -- -- --
Total Revenue 529.33M 481.17M 423.24M 384.10M 338.93M
Cost of Revenue 248.18M 219.50M 189.22M 149.66M 126.64M
Gross Profit 281.15M 261.67M 234.02M 234.44M 212.29M
SG&A Expenses 177.33M 172.86M 168.01M 164.22M 152.28M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 524.86M 496.97M 468.86M 410.33M 366.44M
Operating Income 4.48M -15.80M -45.62M -26.24M -27.51M
Income Before Tax 14.26M -6.31M -36.15M -16.72M -18.02M
Income Tax Expenses 9.47M 10.64M 7.04M -7.66M -7.79M
Earnings from Continuing Operations 4.79 -16.95 -43.19 -9.07 -10.23
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 4.79M -16.95M -43.19M -9.07M -10.23M
EBIT 4.48M -15.80M -45.62M -26.24M -27.51M
EBITDA 5.98M -14.23M -43.92M -24.40M -25.47M
EPS Basic 0.06 -0.24 -0.61 -0.12 -0.14
Normalized Basic EPS 0.12 -0.06 -0.32 -0.15 -0.16
EPS Diluted 0.04 -0.25 -0.61 -0.14 -0.16
Normalized Diluted EPS 0.10 -0.06 -0.32 -0.15 -0.16
Average Basic Shares Outstanding 290.13M 287.70M 285.68M 283.74M 282.20M
Average Diluted Shares Outstanding 298.13M 291.20M 285.68M 286.02M 284.48M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --